Relevant issues in pharmacotherapy of psycho-cutaneous disorders
- PMID: 23372216
- PMCID: PMC3555377
- DOI: 10.4103/0019-5154.105311
Relevant issues in pharmacotherapy of psycho-cutaneous disorders
Abstract
Psychiatric disorders frequently co-occur with dermatological conditions and psychotropic agents may be indicated in treating the underlying psychiatric symptoms. Use of psychotropics can be associated with significant cutaneous adverse effects as well as drug interactions with pharmacological agents used in treatment of the dermatological conditions. Knowledge of indication, contraindication, side effects, and interactions of psycho-tropics is essential for the practicing dermatologist in managing psycho-dermatological conditions. This review aims at discussing relevant issues in pharmacological management of psycho-cutaneous disorders.
Keywords: Pharmacotherapy; psychodermatology; psychotropics.
Conflict of interest statement
References
-
- Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: A randomized controlled trial. JAMA. 2003;290:2693–702. - PubMed
-
- Srinivasan TN, Suresh TR, Jayaram V, Fernandez MP. Nature and treatment of delusional parasitosis: A different experience in India. Int J Dermatol. 1994;33:851–5. - PubMed
-
- Damiani JT, Flowers FP, Pierce DK. Pimozide in delusions of parasitosis. J Am Acad Dermatol. 1990;22:312. - PubMed
-
- Safer DL, Wenegrat B, Roth WT. Risperidone in the Treatment of Delusional Parasitosis: A Case Report. J Clin Psychopharmacol. 1994;17:131–2. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources